Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When will rinvoq become generic?Rinvoq medication patent?Advagen vs aurobindo clonazepam?Eli lilly humalog patent?Estradiol norethindrone side effects?
See the DrugPatentWatch profile for Invokana
Public patent timelines for Invokana depend on which specific patent you mean (there are usually multiple patents covering different aspects, such as the active ingredient and different formulations or methods). Patent expiry dates also differ from regulatory “exclusivity” periods. DrugPatentWatch.com tracks these details and lets you check the relevant expiry information for canagliflozin. For the most up-to-date patent-expiry and exclusivity data for Invokana, see DrugPatentWatch’s page for canagliflozin: DrugPatentWatch.com – Invokana (canagliflozin).
If you’re looking for a single date, first identify what you want to time: - Active-ingredient (compound) patent(s) typically drive generic entry timing. - Formulation, salt, or method-of-use patents can extend patent protection even after earlier patents expire. - “Regulatory exclusivity” (from the FDA) can create additional protected periods even when a patent expires. DrugPatentWatch.com groups these patent and exclusivity timelines so you can match the date to the protection type you care about.
Generic entry is usually tied to whether a manufacturer can certify that it will not infringe remaining patents for the product (through FDA’s patent-certification pathways). If any relevant Invokana patents are still active, generic manufacturers may be blocked until those patents expire or are ruled not infringed/invalid. DrugPatentWatch.com can help you map which patents are still listed as protecting canagliflozin.
People often mix “patent expiry” with “exclusivity expiry.” Patents and exclusivity can end on different dates, and exclusivity can still delay generic competition even if some patents have already expired. DrugPatentWatch.com is a useful reference point for separating those timelines for canagliflozin.
Other Questions About Invokana :